Skip to main content

Table 3 Echocardiographic data of study population according to fT3 concentration

From: Low triiodothyronine syndrome and selenium deficiency - undervalued players in advanced heart failure? A single center pilot study

Characteristics

Group A Low fT3

< 3.10 pml/L

(n = 9)

Group B Normal fT3

≥3.10 pmol/L

(n = 50)

p-value

LVEDD, mm

65.5 (±12.7)

65.6 (±9.9)

0.9483

LVESD, mm

59.0 (±14.0)

55.9 (±11.4)

0.4692

LVEDV, ml

212.9 (±83.4)

238.4 (±86.8)

0.4187

LVESV, ml

178.8 (±76.3)

184.6 (±78.9)

0.8386

SI

0.6 (±0.07)

0.64 (±0.12)

0.3395

LVEF, %

16.1 (±5.7)

25.4 (±7.4)

0.0008

MAPSE, mm

4.0 (3.6–4.8)

7.0 (5.0–8.9)

0.0051

E/A

2.7 (2.2–3.2)

1.3 (0.8–2.2)

0.0082

Number of pts. with restrictive mitral filling pattern, n (%)

5 (8.3%)

13 (46.4%)

0.1801

E/E’

15.2 (±5.6)

17.5 (±8.5)

0.4321

RVSP, mmHg

44.0 (39.0–62.5)

35.0 (31.0–48.5)

0.0794

TAPSE, mm

12.8 (±4.8)

15.8 (±5.0)

0.1066

+dP/dt, mmHg/s

466.0 (404.5–824.5)

606.0 (457.0–757.0)

0.4222

Functional mitral regurgitation, n (%)

5 (55.6%)

21 (42.0%)

0.4885